Antonio Olveira

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa‐2a plus ribavirin†‡

Manuel Romero‐Gómez, M. Diago, Raúl J. Andrade et al. · Hepatology · 2009 · 154 citations

A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis

Sonia Alonso López, María Luisa Manzano, Francisco Gea et al. · Hepatology · 2020 · 93 citations

GS-06-Positive Results from REGENERATE: A Phase 3 International, Randomized, Placebo-Controlled Study Evaluating Obeticholic Acid Treatment for NASH

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · Journal of Hepatology · 2019 · 52 citations

Obesity, Metabolic Syndrome, Sport Nutrition +9

Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities

Abelardo Aguilera, M. Auxiliadora Bajo, Mauricio Espinoza et al. · American Journal of Kidney Diseases · 2003 · 46 citations

Hemodialysis, Urology, Renal Function +8